saRNA Injection Targets Cardiac Injury
March 17, 2026
Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction
1 min read
False
Advertisement
Cell & Gene
Manufacturing Inside the Patient
By Priya Baraniak
March 17, 2026
How 2025 marked biology’s shift toward engineering discipline
3 min read
Armoring CAR-T Against Solid Tumors
March 17, 2026
UCLA researchers create armored CAR-T cells that show promise for treating solid tumors
2 min read
Breaking the Size Barrier in CAR T Engineering
March 16, 2026
An optimized workflow increases lentiviral delivery efficiency for large CAR constructs
1 min read
T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy
March 16, 2026
The first-in-human ATLAS trial will test PRAME-targeting CRISPR T cells in advanced cancers
2 min read
Engineering Safer Editors for Cystic Fibrosis Mutations
March 13, 2026
Modified APOBEC3G editors improve CRISPR base-editing specificity and reduce bystander mutations in human cells
2 min read
Engineering CAR T Cells to Resist Tumor Immune Suppression
March 9, 2026
CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models
2 min read
HEK293 Cell Line for rAAV Manufacturing
March 4, 2026
New study reports two-fold improvement in full-to-empty rAAV ratio versus commercial HEK293 line
2 min read
Refining CAR-NK Design
March 4, 2026
Preclinical findings suggest that receptor design and timed kinase inhibition could help strengthen next-generation cell therapies.
1 min read
A Pharmacologic Off-Switch for Split CARs
March 3, 2026
Study describes a venetoclax-regulated off-switch CAR system with dose-dependent control of receptor assembly in vitro and in vivo
2 min read
